Sun Pharma in $50 million deal with Spanish firm
Indian drug major Sun Pharmaceutical Industries Ltd said it entered into $50 million licensing agreement with Spanish firm Almirall for the development and commercialisation of tildrakizumab for psoriasis in Europe.
Jul 28, 2016, 11:35 AM IST